首页 | 本学科首页   官方微博 | 高级检索  
     

膦甲酸钠临床联合用药的研究概况
引用本文:温海燕,宋金春. 膦甲酸钠临床联合用药的研究概况[J]. 中国感染控制杂志, 2019, 18(1): 89-92. DOI: 10.12138/j.issn.1671-9638.20193734
作者姓名:温海燕  宋金春
作者单位:膦甲酸钠临床联合用药的研究概况
摘    要:膦甲酸钠为广谱非核苷类抗病毒药物,可有效阻断多种DNA病毒的复制,如疱疹病毒、人乳头瘤病毒、乙型肝类病毒、人类免疫缺陷病毒及其相关感染等。膦甲酸钠临床上常与多种药物联合使用,发挥全面抗病毒作用。本文对膦甲酸钠临床联合用药的研究进行综述,包括疱疹、乙型肝炎、人乳头瘤病毒感染的治疗,联合用药的不良反应等。

关 键 词:膦甲酸钠  联合用药  抗病毒  不良反应  
收稿时间:2018-03-19

Research progress of combination clinical application of foscarnet sodium
WEN Hai-yan,SONG Jin-chun. Research progress of combination clinical application of foscarnet sodium[J]. Chinese Journal of Infection Control, 2019, 18(1): 89-92. DOI: 10.12138/j.issn.1671-9638.20193734
Authors:WEN Hai-yan  SONG Jin-chun
Affiliation:Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan 430060, China
Abstract:Foscarnet sodium is a broad-spectrum non-nucleoside antiviral drug which can effectively block the replication of various DNA viruses such as herpes virus, human papillomavirus, hepatitis B virus, human immunodeficiency virus and related infections. Foscarnet sodium is often used in combination with a variety of drugs in clinic to play a full role in antivirus. In this paper, the research on the combination use of foscarnet sodium in clinic, including the treatment of herpes, hepatitis B, human papillomavirus infection, and adverse reactions of combination therapy are reviewed.
Keywords:foscarnet sodium  combination therapy  antivirus  adverse reaction
本文献已被 CNKI 等数据库收录!
点击此处可从《中国感染控制杂志》浏览原始摘要信息
点击此处可从《中国感染控制杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号